Literature DB >> 10928143

Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer.

A S Papathoma1, C Petraki, A Grigorakis, H Papakonstantinou, V Karavana, S Stefanakis, F Sotsiou, A Pintzas.   

Abstract

BACKGROUND: The levels of matrix metalloproteinases MMP-2 and MMP-9 (type IV collagenases), which degrade the extracellular matrix of the basement membrane, were evaluated as prognostic indicators of metastasis in urothelial carcinoma.
MATERIALS AND METHODS: Quantitative gel zymography and immunohistochemistry were used and compared with clinical data at the follow-up period of 36 months.
RESULTS: Zymographical analysis of the levels of MMP-9 and active MMP-2 showed a statistically significant increase with tumor grade and invasiveness. This correlation was confirmed by immunohistochemical analysis of MMP-9 expression. However, the correlation between the levels of both gelatinases with recurrence in superficial tumours or progression in invasive tumours was not statistically significant.
CONCLUSION: MMPs may have an important role in the invasion mechanism of urothelial cancer and could be useful prognostic markers for patients with bladder carcinoma. The relationship between MMP-2 and MMP-9 expression and the metastatic potential of bladder carcinoma needs further evaluation in subsequent clinical studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928143

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

1.  Expression of matrix metalloproteinase-9 correlates with poor prognosis in human malignant fibrous histiocytoma.

Authors:  Jinyoung Yoo; Ji Han Jung; Seok Jin Kang; Chang Suk Kang
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

Review 2.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors:  Roopali Roy; Jiang Yang; Marsha A Moses
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

3.  Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.

Authors:  Emeline Tabouret; Françoise Boudouresque; Maryline Barrie; Mona Matta; Celine Boucard; Anderson Loundou; Antoine Carpentier; Marc Sanson; Philippe Metellus; Dominique Figarella-Branger; L'houcine Ouafik; Olivier Chinot
Journal:  Neuro Oncol       Date:  2013-12-09       Impact factor: 12.300

4.  Requirement of arsenic biomethylation for oxidative DNA damage.

Authors:  Chikara Kojima; Dario C Ramirez; Erik J Tokar; Seiichiro Himeno; Zuzana Drobná; Miroslav Stýblo; Ronald P Mason; Michael P Waalkes
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 13.506

Review 5.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

6.  Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells.

Authors:  Hanief M Shahjee; Kristopher R Koch; Li Guo; Chen-Ou Zhang; Susan K Keay
Journal:  J Exp Clin Cancer Res       Date:  2010-12-10

7.  Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.

Authors:  Andrea Staack; Steffen Badendieck; Dietmar Schnorr; Stefan A Loening; Klaus Jung
Journal:  BMC Urol       Date:  2006-08-10       Impact factor: 2.264

8.  How Cancer Cells Invade Bladder Epithelium and Form Tumors: The Mouse Bladder Tumor Model as a Model of Tumor Recurrence in Patients.

Authors:  Andreja Erman; Urška Kamenšek; Urška Dragin Jerman; Mojca Pavlin; Maja Čemažar; Peter Veranič; Rok Romih
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

9.  Matrix Metalloproteinases and Bladder Cancer: What is New?

Authors:  O Rodriguez Faba; J Palou-Redorta; J M Fernández-Gómez; F Algaba; N Eiró; H Villavicencio; F J Vizoso
Journal:  ISRN Urol       Date:  2012-07-17

10.  Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura.

Authors:  J G Edwards; J McLaren; J L Jones; D A Waller; K J O'Byrne
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.